Lactosorb Brochure Spanish - Lactosorb Brochure Journal Article - Resorbable System strength performance - A comparison Journal Article - Outcomes and complications Journal Article - JOMS,fixation of bimaxillary osteotomies. Journal Article - PRS, reossification of the orbital wall Article - Comparison of Titanium and Resorbable Copolymer Fixation after Le Fort IReyneke Journal Article - OSOMOPOR, mandibular sagittal split osteotomies. Journal Article - JOMS, use of resorbable plates and screws in ped Article Journal - JOMS, using resorbable screws for fixation Journal Article - PRS, Resorbable PLLA-PGA Journal Article - PRS, The use of resorbable spacers Journal Article - JCS, Reconstruction of Traumatic Orbital Floor Fractures Journal Article -JCS, Application of the spanning plate concept Warnings and Precautions 01-50-1050 Warnings and Precautions 01-50-1052 Warnings and Precautions 01-50-1054 Warnings and Precautions 01-50-1056

LactoSorb® SE: The Leader In Resorbable Technology.

First introduced in 1996, the LactoSorb® plating system represented a major step forward in craniomaxillofacial fixation. Now, with over 10 years of clinical history and no change to the original formulation, the LactoSorb plating system remains the most thoroughly proven product of its kind.

Since its introduction, LactoSorb has been used successfully in more than 50,000 craniomaxillofacial cases. The extensive clinical history of LactoSorb has resulted in its acceptance by an ever growing number of surgeons.  

Total Resorption In One Year Or Less
LactoSorb® is the only clinically proven material that completely resorbs and is eliminated from the body within one year.

At initial placement, its strength is equal to that of titanium plating. It retains seventy percent of its initial strength out to eight weeks, allowing for complete osseous union in the craniomaxillofacial skeleton.

Because of its unique co-polymer chemistry, LactoSorb SE resolves a wide range of issues, including implant palpability, bone-growth restriction, transcranial migration, late-stage inflammatory reaction and temperature sensitivity. LactoSorb SE is highly effective both in pediatric and adult patients.

LactoSorb SE is 510k cleared in the United States and carries the CE Mark, HPB and TGA approval. 

• Infant craniofacial surgery
• Pediatric reconstructive procedures
• Pediatric mid-face and craniofacial trauma
• Craniotomy flap fixation
• Brow-lift procedures
• Bone-graft procedures in the mid-face, mandible or craniofacial skeleton 
• Trauma and reconstructive procedures of the mid-face or craniofacial skeleton, including frontal,  parietal, temporal, sphenoid and occipital bones 
• Fractures of the maxilla, zygoma, zygomatic arch, orbital rim, frontal sinus wall, nasal, ethmoid and lacrimal bones
• Iliac crest graft cover
• Mandibular osteotomies
• Tumor reconstruction in the mid-face or craniofacial procedures
• Lefort fractures (I,II,III)